Harrington Discovery Institute
Overview
Harrington Discovery Institute is a non-profit medical accelerator based at University Hospitals in Cleveland, Ohio. It focuses on advancing breakthrough discoveries by physician-scientists into novel treatments, addressing the 'valley of death' in drug development by providing funding and support to early-stage projects. The institute collaborates with academic medical centers, research institutions, and universities across the United States, United Kingdom, and Canada to identify and de-risk promising therapeutic candidates. The institute's strategy includes offering grant funding, drug and business development support, and opportunities for acceleration and investment funds. Through partnerships with organizations like Advent Life Sciences, BioMotiv, and the Oxford-Harrington Rare Disease Centre, Harrington Discovery Institute aims to advance medicines for unmet needs, particularly in rare diseases. Its portfolio encompasses a wide range of therapeutic areas, including oncology, neurology, cardiology, and immunology. Harrington Discovery Institute's philosophy centers on a collaborative, non-profit/for-profit model that integrates drug development expertise, financial resources, and industry collaborations. This approach has led to the advancement of numerous medicines into clinical trials and commercialization, demonstrating a commitment to translating innovative scientific discoveries into tangible health solutions for patients worldwide.
Investment Focus
- Innovative medical discoveries with potential for clinical impact
- Projects in need of early-stage funding and development support
- Collaborative initiatives with academic and research institutions
Portfolio Companies
Reach Harrington Discovery Institute directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Harrington Discovery Institute
What sectors does Harrington Discovery Institute invest in?
Harrington Discovery Institute invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Oncology, and is based in Ohio, United States. Harrington Discovery Institute is listed as a venture capital in the ConnectSafely investor database.
What stage does Harrington Discovery Institute invest at?
Harrington Discovery Institute backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 100K - 2M.
Which regions does Harrington Discovery Institute invest in?
Harrington Discovery Institute invests across United States, United Kingdom and Canada.
What companies has Harrington Discovery Institute invested in?
Harrington Discovery Institute's portfolio includes AlveoGene, SapVax, Inclera, Orca Therapeutics, Koutif Therapeutics, Nynex Therapeutics, Optikira and Sujana.
Last updated · Source: ConnectSafely investor database
